🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$TMDX gapped down today, filling the May 9th gap—and found strong buyers. This could mark the end of the downtrend. Too early to call it for sure, but the action speaks. Let’s see if the trend flips. #TMDX #PriceAction

$TMDX just posted very very interesting job posting just now on LinkedIn. Clinical Trial Manager. Look at Job description that mention activities that is supposed to be done to manage trial execution. Did we got it Waleed? will find out only on July 30th at 4:05 PM?

$CDTX +137% gap on Ph2b flu data (76% efficacy) Volume: 19M (>20x avg) — 🚀 breakout confirmed 4 weeks of tight, high-volume accumulation 📈 1-week low-volume pullback — no distribution Classic institutional footprint 🧠 This setup’s got serious legs.

Humans are the best and worst animals. At our worst—we betray, rape, and kill our own. At our best—we die for strangers, fight for justice, and love beyond reason. No other species holds such darkness and such light. It’s the choices we make that define our humanity

As a preventive cardiologist, I can attest to following: 🚨 Heart disease often strikes without warning. • ~50% of people who die from a heart attack had no prior diagnosis • Up to 58% of sudden cardiac deaths are the first sign of heart disease • Many never make it to the

🫀 Half of all heart attack deaths happen with no prior warning. Yet current guidelines don’t recommend routine screening in asymptomatic people. We screen for cancers with lower mortality. It’s time to broaden heart disease screening—before “healthy” people die suddenly.

0.1–0.5% of “healthy” adults live with a silent but treatable cancer. That’s ~15–20M people worldwide, ~3M in Europe, ~1M in the US. Radiology and liquid biopsy can help detect more of them. But prevention matters most: reduce lifestyle and environmental risks.

$ABVX just exploded +580% on Phase 3 data. 11x volume This isn’t retail FOMO—it’s smart money conviction. Is this just the beginning of a bigger trend, or the peak of euphoria? I am leaning towards trend. Key levels to watch: • $72 = gap high • $80 = psychological

Lp(a) is a special type of Low density lipoprotein with an extra protein—apo(a)—that makes it stickier, more inflammatory, and over 6× more atherogenic than regular LDL. Don't get fooled by normal LDL-C It doesn’t show up on your standard cholesterol test. And it

$TMDX For the most part, we already have a sense of what this quarter’s revenue will look like. What remains uncertain is how the market will react to the earnings report and the tone of the earnings call.

🚨 TMDX Q2 Earnings Blowout – EPS: $0.92 (vs est. $0.45) ✅ – Revenue: $157.4M (vs est. $147M) ✅ – EPS growth: +100% YoY 📈 – Revenue growth: +38% YoY Transplant volumes booming. Margins expanding. Raised guidance . New ATH coming ? #Stocks #Earnings #MedTech

After hour close on $TMDX looking good!

$TMDX is exploding premarket on a TRIFECTA ✅ Blowout EPS growth ✅ Revenue beat ✅ Raised guidance And here’s the kicker: 25% of the float is short. This isn’t just momentum. It’s a full-blown squeeze ignition. Prayers up for the shorts. 🕯️🚀

All 3 major indexes closed down sharply today. Yet $TMDX and $MP bucked the trend—both went from red to green. When stocks close strong on a weak tape, it's telling.

Peter Schiff wants to scrap the FDA’s efficacy requirement to lower drug prices. Sounds free-market friendly—until patients start dying from useless meds. Cheaper isn’t better if the drugs don’t work. We learned this the hard way in 1962. Let’s not unlearn it. Real solutions?

AMEN. As one of the few “sterologists,” (a subspecialty of lipidology), I have been teaching this for > than a decade. New (not really) Research Shows Eggs Don't Raise Your Cholesterol—But Here's What Does health.com/research-shows…